{"id":"40-diluted-autologous-serum","safety":{"commonSideEffects":[{"rate":null,"effect":"Local irritation"},{"rate":null,"effect":"Infection risk"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":{"chemblId":"CHEMBL2109149","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Autologous serum therapy uses a patient's own blood serum, typically diluted to 40% concentration, to deliver endogenous immunoglobulins, cytokines, and growth factors that modulate local immune responses and reduce inflammation. The mechanism is thought to involve both specific and non-specific immune regulation, promoting tissue healing and reducing pathological inflammation at the site of application.","oneSentence":"Diluted autologous serum provides immunomodulatory and anti-inflammatory effects through patient-derived serum factors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:23:23.946Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Ocular surface disease"},{"name":"Corneal ulceration"}]},"trialDetails":[{"nctId":"NCT02752763","phase":"PHASE4","title":"Comparison of Autologous Serum Versus Preservative Free Artificial Tear","status":"COMPLETED","sponsor":"Niğde State Hospital","startDate":"2015-10","conditions":"Dry Eye","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"%40 diluted Autologous serum","genericName":"%40 diluted Autologous serum","companyName":"Niğde State Hospital","companyId":"ni-de-state-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diluted autologous serum provides immunomodulatory and anti-inflammatory effects through patient-derived serum factors. Used for Dry eye syndrome, Ocular surface disease, Corneal ulceration.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}